Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer

Go back to Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer
(NASDAQ: NTHI) Delayed: 3.87 +0.19 (5.16%)
Previous Close $3.68    52 Week High
Open $3.83    52 Week Low
Day High $3.88    P/E N/A 
Day Low $3.74    EPS
Volume 18,376